Evidence for Presynaptic Damage in Myasthenia Gravis

  • Chuan-Zhen Lu
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 363)


Myasthenia Gravis (MG) has been considered as an autoimmune disease at neuromuscular junction caused by circulating antibodies to acetylcholine receptors (AchR) since 1973. Antibodies to AchR can be detected in 65–95 % sera from patients with MG. In the mean time, no correlation between the antibodies titer and severity of symptoms of the disease was found. Experiemntal myasthenia gravis (EAMG) not only can be induced by injection of antibodies to AchR positive sera from MG patients, but also can be induced by injecting sera with undetectable antibody to AchR. The last few years, we looked into other factors in the pathogenesis of myasthenia Gravis.


Antibody Titer Neuromuscular Junction Normal Plasma Wheat Germ Agglutinin Demyelinating Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Chuan-Zhen Lu
    • 1
  1. 1.WHO Collaborating Center for Training and Research in NeurosciencesShanghai Medical UniversityShanghaiPeople’s Republic of China

Personalised recommendations